Research Papers

25 of 582 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and the…
Ren X; Cui H; Dai L; Chang L; Liu D; Yan W; Zhao X; Kang H; Ma X.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma.
Zhang T; Wang ZT; Li Z; Yin SX; Wang X; Chen HZ.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway.
Wang R; Li R; Yang H; Chen X; Wu L; Zheng X; Jin Y.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors.
Ding Y; Zhou Q; Ding B; Zhang Y; Shen Y.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Treatment of poorly differentiated neuroendocrine carcinomas of rectum and anus with chemoradiotherapy: a single-centre…
Fløe LE; Aggerholm-Pedersen N; Tabaksblat EM.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical outcomes of patients with CIC-rearranged sarcoma: a single institution retrospective analysis.
Murphy J; Resch EE; Leland C; Meyer CF; Llosa NJ; Gross JM; Pratilas CA.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung canc…
Ma M; Luo M; Liu Q; Zhong D; Liu Y; Zhang K.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma.
Mengzhen Z; Xinwei H; Zeheng T; Nan L; Yang Y; Huirong Y; Kaisi F; Xiaoting D; Liucheng Y; Kai W.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer.
Marks MP; Giménez CA; Isaja L; Vera MB; Borzone FR; Pereyra-Bonnet F; Romorini L; Videla-Richardson GA; Chasseing NA; Calvo JC; Vellón L.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Advances in the antitumor mechanisms of tripartite motif-containing protein 3.
Teng W; Ling Y; Liu Z; Jiang L; Fu G; Zhou X; Long N; Liu J; Chu L.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Helicobacter pylori upregulates circPGD and promotes development of gastric cancer.
Zhao W; Yao Z; Cao J; Liu Y; Zhu L; Mao B; Cui F; Shao S.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A novel EIF3C-related CD8<sup>+</sup> T-cell signature in predicting prognosis and immunotherapy response of nasopharyn…
Li R; Wang Y; Wen X; Cheng B; Lv R; Chen R; Hu W; Wang Y; Liu J; Lin B; Zhang H; Zhang E; Tang X.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
CSMed<sup>®</sup> wound dressing for prophylaxis and management of radiation dermatitis in breast and head-neck cancer …
Lee YC; Tseng HC; Yang HF; Lee YH; Ko YF; Chang ST; Chen HL; Chang BJ; Chou YH.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Machine learning predicts the risk of osteoporosis in patients with breast cancer and healthy women.
Zhao F; Li C; Wang W; Zhang Y; Yao P; Wei X; Jia Y; Dang S; Zhang S.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by …
Wu C; Chen S; Wu Z; Xue J; Zhang W; Wang S; Xindong Zhao; Wu S.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.
Harsanyi S; Kianickova K; Katrlik J; Danisovic L; Ziaran S.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tumor-to-stroma cd8<sup>+</sup> t cells ratio combined with cancer-associated fibroblasts: an innovative approach to pr…
Guo S; Chen P; Yang Y; Wei W; Pan Y; Zeng F; Fan L; Wang W.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent ch…
Zhong N; Yu D; Yang M; Lu X; Zhang Q; Wei W; Jiao J; Yang X; Zhu Z; Chen S; Xiao J.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cance…
Kuribayashi T; Ohashi K; Nishii K; Ninomiya K; Tsubata Y; Ishikawa N; Kodani M; Kanaji N; Yamasaki M; Fujitaka K; Kuyama S; Takigawa N; Fujimoto N; Kubota T; Inoue M; Fujiwara K; Harita S; Takata I; Takada K; Okawa S; Kiura K; Hotta K.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transiti…
Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Overexpression of aquaporin-1 plays a vital role in proliferation, apoptosis, and pyroptosis of Wilms' tumor cells.
Liu H; Jin C; Xia N; Dong Q.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer.
Fan X; Zhang Q; Qin S; Ju S.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in pati…
Olbrich A; Niemeyer J; Seiffert H; Ebel S; Gros O; Lordick F; Forstmeyer D; Seehofer D; Rademacher S; Denecke T; Matz-Soja M; Berg T; van Bömmel F.
J Cancer Res Clin Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared